Navigation Links
GlySure Wins 2013 Small Business of the Year and New Product of the Year

OXFORD, England, October 1, 2013 /PRNewswire/ --

GlySure Limited, developer of in-hospital continuous blood glucose monitoring (CBGM) systems, today announced that it has won two major awards in the 2013 BIG (Business Intelligence Group) Awards for Business.

BIG has selected GlySure as Small Business of the Year and it also won New Product of the Year for its CBGM technology.

Business Intelligence Group's BIG Awards specialize in recognizing top performing companies and organizations. The organization's proprietary and unique scoring system selectively measures performance across multiple business domains, and rewards companies whose achievements stand above those of their peers.

"Glysure's mission and product to help control glucose levels in real time is clearly in demand," said Dawn Fordyce of the Business Intelligence Group. "With so much at stake, Glysure's continuous blood glucose monitoring system will surely save countless lives and healthcare costs."

Over two years of human use trials in over 150 intensive care unit (ICU) patients have proven that GlySure's CBGM technology can be used to continuously measure glucose levels with an extremely high degree of accuracy and repeatability across three-to-five days of a patient's stay, which is key to improving outcomes and reducing costs in the ICU. GlySure recently commenced a multi-center CE Trial on cardiac surgery patients, which the company expects to complete this fall.

"It is a great honor to be recognized by the Business Intelligence Group," said GlySure CEO Chris Jones. "This industry recognition validates the tremendous momentum we've achieved to date in delivering on the promise of Tight Glycemic Control."

About GlySure:

GlySure has developed a continuous intravascular glucose monitoring system using a proprietary optical fluorescence sensor to meet the $2B+ worldwide demand for implementation of Tight Glycemic Control (TGC) in the hospital Intensive Care Unit (ICU).  The company has demonstrated through ICU testing highly accurate sensors which can provide continuous glucose readings throughout the length of a patient's stay in the ICU. GlySure was founded in 2006, it is based in Abingdon, Oxfordshire, England and it has 30 employees. The company's products are not approved for use in the U.S. or Europe.

Company Contact: Chris Jones, CEO, GlySure. Tel: +44(0)1235-462-870.

Media Contact: Kara Della Vecchia, KDV Communications, Inc. Tel: +1-508-314-3127.

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Glysure Appoints Justine McQuillan as European Director of Clinical Affairs
2. Study Demonstrates Glysure Systems Ability to Accurately Measure Blood Glucose Levels in the ICU
3. GlySure CEO to Present ICU Trial Results at Spring Medtech Industry Conferences
4. GlySure Earns ISO 13485 Certification
5. MabVax Therapeutics Receives $1,750,000 Small Business Innovation Research Contract Award From The National Cancer Institute To Support Development of Novel Pancreatic Cancer Diagnostic Imaging Agent
6. GlaxoSmithKline, Community Care of North Carolina harness "small data" to improve patient care and reduce health care costs
7. PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
8. PDL BioPharma to Present at the 4th Annual Credit Suisse Small/Mid Cap Conference
9. Arisaph Pharmaceuticals Awarded Phase I STTR Grant To Develop Small Molecule Immune Modulators
10. Alzheimers Drug Discovery Foundation Supports Madera Biosciences to Advance Small Molecule Drugs that Upregulate apoE
11. Structure-Based Drug Design Conference in Boston, Starting June 19 PLUS These 62 Start-ups and Small Companies Will Transform Drug Delivery Technology
Post Your Comments:
(Date:11/25/2015)... SYDNEY , Nov. 26, 2015  The total global ... nearly 7% over 2015-2016. Latin America ... Asia , (excluding Japan ), is ... continues to face increased healthcare expenditure. In 2013-2014, ... expenditure declined from 43.5% in 2008-2009 to 41.2% in 2013-2014. ...
(Date:11/25/2015)... , Nov. 25, 2015 On Tuesday, ... federal bellwether trial against Wright Medical Technology, Inc. ... their Conserve metal-on-metal hip implant device, awarded $11 ... a two week trial and three days of ... hip device was defectively designed and unreasonably dangerous, ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015  Trovagene, ... molecular diagnostics, today announced that Chief Executive Officer Antonius ... at the 27 th Annual Piper Jaffray Healthcare ... Conference at the New York Palace Hotel in ... 2015 at 1:30 p.m. EST. Mr. Schuh will be ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... ... aggressive than those found on mammography, according to a study published online in ... cancers not seen on mammography may necessitate a change in treatment. , Breast ...
(Date:11/25/2015)... MN (PRWEB) , ... November 25, 2015 , ... ... launched offering factory direct sauna parts and accessories. , Sauna accessories help ... of the bather’s style and personality. From basic styles for the purist looking ...
(Date:11/25/2015)... , ... November 25, 2015 , ... According to an ... robot is being more and more widely heralded as a breakthrough for performing hernia ... method has over traditional laparoscopic surgery is that it can greatly reduce the pain ...
(Date:11/25/2015)... Crystal Lake, IL (PRWEB) , ... November 25, 2015 , ... ... pleased to announce a recent successful appellate decision obtained by Attorneys Francisco J. Botto ... the case Adcock v. Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... of music, friendships, and learning in its 65th Anniversary Brillianteen Revue, scheduled for ... , For 65 years, Brillianteen has been a treasured tradition for ...
Breaking Medicine News(10 mins):